Status:

COMPLETED

Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects

Lead Sponsor:

University of Wisconsin, Madison

Collaborating Sponsors:

Nephro-Tech 1, LLC

Conditions:

Healthy

Eligibility:

FEMALE

18-65 years

Phase:

PHASE1

Brief Summary

This is a Phase I, single center, open-label study of the dietary supplement calcium formate in normal, healthy female subjects. The purpose of the study is to determine whether daily use of calcium f...

Detailed Description

This is a Phase I, single center, open-label study of the dietary supplement calcium formate in normal, healthy female subjects. The purpose of the study is to determine whether daily use of calcium f...

Eligibility Criteria

Inclusion

  • Healthy females

Exclusion

  • no ocular diseases

Key Trial Info

Start Date :

July 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2007

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT00204893

Start Date

July 1 2003

End Date

March 1 2007

Last Update

March 7 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Wisconsin Hospital and Clinics

Madison, Wisconsin, United States, 53792

Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects | DecenTrialz